Factors associated with the efficacy of intravenous methylprednisolone in moderate-to-severe and active thyroid-associated ophthalmopathy: A single-centre retrospective study

MLA

Bingyin Shi, et al. “Factors Associated with the Efficacy of Intravenous Methylprednisolone in Moderate-to-Severe and Active Thyroid-Associated Ophthalmopathy: A Single-Centre Retrospective Study.” Clinical Endocrinology, vol. 90, no. 1, Aug. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ab4d6b65d3faa8d75acbcb591f0fc06e&authtype=sso&custid=ns315887.

APA

Bingyin Shi, Shiqian Hu, Yue Wang, Xi Ding, Meng Zhang, & Mingqian He. (2018). Factors associated with the efficacy of intravenous methylprednisolone in moderate-to-severe and active thyroid-associated ophthalmopathy: A single-centre retrospective study. Clinical Endocrinology, 90(1).

Chicago

Bingyin Shi, Shiqian Hu, Yue Wang, Xi Ding, Meng Zhang, and Mingqian He. 2018. “Factors Associated with the Efficacy of Intravenous Methylprednisolone in Moderate-to-Severe and Active Thyroid-Associated Ophthalmopathy: A Single-Centre Retrospective Study.” Clinical Endocrinology 90 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ab4d6b65d3faa8d75acbcb591f0fc06e&authtype=sso&custid=ns315887.